Nodding syndrome research, lessons learned from the NSETHIO project.
Epilepsy
etiology
nodding syndrome
onchocerciasis
prevalence
Journal
Global mental health (Cambridge, England)
ISSN: 2054-4251
Titre abrégé: Glob Ment Health (Camb)
Pays: England
ID NLM: 101659641
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
02
2019
revised:
04
09
2019
accepted:
19
09
2019
entrez:
7
12
2019
pubmed:
7
12
2019
medline:
7
12
2019
Statut:
epublish
Résumé
Until recently, nodding syndrome (NS) was considered as a mysterious disease of unknown etiology. A link between onchocerciasis and epilepsy was suspected for a long time. However, onchocerciasis was not considered as the cause of NS because NS was believed to occur only in onchocerciasis-endemic regions in Uganda, South Sudan, and Tanzania. In October 2015, with funding from the European Research Council, the NSETHIO group launched a trans-disciplinary, multi-country research project to identify the cause of NS and to study the link between onchocerciasis and epilepsy. We reviewed NSETHIO activities as well as all published papers, and compared project findings with results of previous research on NS. Findings from the NSETHIO project showed that NS is only one of the clinical manifestations in the wide spectrum of onchocerciasis-associated epilepsy (OAE) that could be prevented by strengthening onchocerciasis elimination programs. NSETHIO demonstrated that OAE is an important neglected public health problem in onchocerciasis-endemic areas with no or a sub-optimally functioning onchocerciasis control strategies. Today there is overwhelming evidence that NS together with the Nakalanga syndrome is clinical presentations of OAE, a condition that could be prevented by strengthening onchocerciasis elimination programs. While research needs to continue to elucidate the pathophysiological mechanisms causing NS, new strategies to accelerate onchocerciasis elimination coupled with community-based surveillance and treatment programs for epilepsy are urgently needed in areas of high
Sections du résumé
BACKGROUND
BACKGROUND
Until recently, nodding syndrome (NS) was considered as a mysterious disease of unknown etiology. A link between onchocerciasis and epilepsy was suspected for a long time. However, onchocerciasis was not considered as the cause of NS because NS was believed to occur only in onchocerciasis-endemic regions in Uganda, South Sudan, and Tanzania. In October 2015, with funding from the European Research Council, the NSETHIO group launched a trans-disciplinary, multi-country research project to identify the cause of NS and to study the link between onchocerciasis and epilepsy.
METHODS
METHODS
We reviewed NSETHIO activities as well as all published papers, and compared project findings with results of previous research on NS.
RESULTS
RESULTS
Findings from the NSETHIO project showed that NS is only one of the clinical manifestations in the wide spectrum of onchocerciasis-associated epilepsy (OAE) that could be prevented by strengthening onchocerciasis elimination programs. NSETHIO demonstrated that OAE is an important neglected public health problem in onchocerciasis-endemic areas with no or a sub-optimally functioning onchocerciasis control strategies.
CONCLUSIONS
CONCLUSIONS
Today there is overwhelming evidence that NS together with the Nakalanga syndrome is clinical presentations of OAE, a condition that could be prevented by strengthening onchocerciasis elimination programs. While research needs to continue to elucidate the pathophysiological mechanisms causing NS, new strategies to accelerate onchocerciasis elimination coupled with community-based surveillance and treatment programs for epilepsy are urgently needed in areas of high
Identifiants
pubmed: 31807310
doi: 10.1017/gmh.2019.24
pii: 00024
pmc: PMC6880249
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e26Informations de copyright
© The Author(s) 2019.
Références
Lancet. 1994 Jan 15;343(8890):183-4
pubmed: 7904037
Lancet. 1983 Feb 12;1(8320):358
pubmed: 6130361
J Alzheimers Dis. 2017;60(1):183-200
pubmed: 28826180
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Infect Dis Poverty. 2019 Feb 10;8(1):11
pubmed: 30738437
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Bull Soc Pathol Exot. 2006 May;99(2):103-7
pubmed: 16821440
BMC Res Notes. 2016 Mar 22;9:182
pubmed: 27005304
Infect Dis Poverty. 2018 Oct 8;7(1):79
pubmed: 30293530
Brain. 2016 Sep;139(Pt 9):2441-55
pubmed: 27497924
Infect Dis Poverty. 2018 Dec 3;7(1):114
pubmed: 30501640
Parasit Vectors. 2019 Mar 19;12(1):114
pubmed: 30890155
Epilepsy Behav. 2019 Jan;90:295
pubmed: 30282593
Infect Dis Poverty. 2019 May 24;8(1):35
pubmed: 31122275
Int J Infect Dis. 2016 Aug;49:1-8
pubmed: 27210267
Neurobiol Dis. 2019 Jun;126:124-136
pubmed: 30010004
PLoS Negl Trop Dis. 2019 Jul 18;13(7):e0007407
pubmed: 31318857
Wkly Epidemiol Rec. 2011 Dec 16;86(51-52):581-5
pubmed: 22191103
Ann Trop Med Parasitol. 1959 Apr;53(1):97-102
pubmed: 13650495
Infect Dis Poverty. 2018 Sep 19;7(1):101
pubmed: 30253788
Acta Neuropathol. 2018 Nov;136(5):691-697
pubmed: 30219940
PLoS Negl Trop Dis. 2017 Jul 14;11(7):e0005732
pubmed: 28708828
PLoS Negl Trop Dis. 2010 Jun 29;4(6):e728
pubmed: 20628595
Trends Parasitol. 2018 Mar;34(3):208-216
pubmed: 29288080
PLoS One. 2013 Jun 18;8(6):e66419
pubmed: 23823012
Infect Dis Poverty. 2018 Jul 3;7(1):63
pubmed: 29966535
Seizure. 2018 Nov;62:108-115
pubmed: 30340162
Infect Dis Poverty. 2018 Dec 4;7(1):115
pubmed: 30509330
Infect Dis Poverty. 2019 Jan 23;8(1):8
pubmed: 30670093
Infect Dis Poverty. 2018 Aug 1;7(1):68
pubmed: 30064504
Sci Transl Med. 2017 Feb 15;9(377):
pubmed: 28202778
Infect Dis Poverty. 2018 Mar 22;7(1):23
pubmed: 29580280
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
Epilepsia Open. 2017 Apr 26;2(2):145-152
pubmed: 29588943
Int J Infect Dis. 2014 Oct;27:74-7
pubmed: 25181949
East Afr Med J. 1950 Sep;27(9):339-59
pubmed: 14793447
Lancet Neurol. 2003 Dec;2(12):714
pubmed: 14649236
Int J Infect Dis. 2019 Feb;79:187-194
pubmed: 30711145
Parasitology. 2010 Sep;137(10):1559-68
pubmed: 20388236
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1049-1058
pubmed: 31553445
Fortschr Neurol Psychiatr Grenzgeb. 1964 May;32:213-59
pubmed: 14147859
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300
pubmed: 31314757
Seizure. 2018 Dec;63:93-101
pubmed: 30468964
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319
Tropenmed Parasitol. 1976 Jun;27(2):123-32
pubmed: 941247